ISSCR News
![ISSCR Voice is Heard on Capitol Hill](https://images.squarespace-cdn.com/content/v1/611faaa8fee682525ee16489/1658438811090-YAOR2H3901FJQFL40RKV/unsplash-image-DoA2duXyzRM.jpg)
ISSCR Voice is Heard on Capitol Hill
In mid-September, the U.S. Senate debated and passed a spending bill that included an increase in funding for the Department of Health and Human Services. The bill did not include a ban on federal funding for fetal tissue research, a measure the ISSCR opposed in a letter to leaders of the U.S. House and Senate, signed by 64 organizations.
![ISSCR Responds to U.S. Department of Health and Human Services Decision Regarding Fetal Tissue Research](https://images.squarespace-cdn.com/content/v1/611faaa8fee682525ee16489/1658438912702-HC3F68A032HXZN91GEPK/unsplash-image-hIgeoQjS_iE.jpg)
ISSCR Responds to U.S. Department of Health and Human Services Decision Regarding Fetal Tissue Research
The ISSCR is troubled by the recent decision by the U.S. Department of Health and Human Services to “conduct a comprehensive review of all fetal tissue research.” The directive appears to come after intensive lobbying efforts by special interest groups with the goals of delaying or curtailing scientific research that relies on fetal tissue. Fetal tissue research has been necessary for the development of vaccines and therapies that have saved millions of lives, and continues to be important for the future of medicine. Decisions about how best to conduct research and to advance human health should be based on science and medicine, not ideology or politics.
![ISSCR Opposes Proposal to Restrict Fetal Tissue Research](https://images.squarespace-cdn.com/content/v1/611faaa8fee682525ee16489/1658439053427-EUASWFWY8PO1NKMZ9XJU/unsplash-image--LCkOaso6rg.jpg)
ISSCR Opposes Proposal to Restrict Fetal Tissue Research
The ISSCR, the largest professional organization of stem cell researchers from around the world, opposes the U.S. House of Representatives proposal to ban federal funding for fetal tissue research. ISSCR President Hans Clevers released the following statement…
![ISSCR Responds to President Trump Signing 'Right to Try' Law](https://images.squarespace-cdn.com/content/v1/611faaa8fee682525ee16489/1658439160003-792RFN0F8DQXRQP7HFLK/unsplash-image-DZpc4UY8ZtY.jpg)
ISSCR Responds to President Trump Signing 'Right to Try' Law
The ISSCR is disappointed with the enactment of the ‘Right to Try’ law. Along with more than 100 patient and research groups opposing the bill, we believe it will put patients at risk and undermine the effective FDA Expanded Access Program already in place to give seriously ill patients access to experimental treatments.
![ISSCR Applauds Federal Injunctions Against Stem Cell Clinics](https://images.squarespace-cdn.com/content/v1/611faaa8fee682525ee16489/1658439237903-I31805IW9VU6BZPP07BW/unsplash-image-nMyM7fxpokE.jpg)
ISSCR Applauds Federal Injunctions Against Stem Cell Clinics
The ISSCR is pleased that federal prosecutors in the U.S. have taken action to halt the marketing and delivery of unproven stem cell treatments at clinics they allege are operating outside of FDA regulation: California Stem Cell Treatment Center, Cell Surgical Network Corporation, and U.S. Stem Cell Clinic in Florida…
![](https://images.squarespace-cdn.com/content/v1/611faaa8fee682525ee16489/1e898b25-2b77-4f85-aea4-e33ef01a920e/mouse+neural+stem+cell.jpg)
Receive ISSCR Press Releases
Sign up be a part of ISSCR’s media list. Media Contact: Kym Kilbourne, Director of Media and Strategic Communications
Subscribe to ISSCR News.
Each month, ISSCR delivers scientific, policy, and community to your inbox .